Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns

August 20, 2020 Auto Bot Anthony Fauci, BioPharma, biopharma nl, convalescent plasma, FDA, Food and Drug Administration, National Institute of Allergy and Infectious Diseases, National Institutes of Health, NIAID, NIH, Policy, SARS-CoV-2 0

The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.